Clinical trial
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole…
NCT00259051 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00259051 |
|---|---|
| Title | A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population |
| Official title | A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Investigate the Pharmacodynamic Effect by Assessment of the 24 Hours Intraesophageal pH Level, the Efficacy and Safety of Omeprazole 10mg and 20mg od in Patients With Non-erosive Reflux Disease (NERD). |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-erosive Reflux Disease |
| Intervention type | Drug |
| Interventions | Omeprazole |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Nov 29, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: